CNTX · Context Therapeutics Inc.
$0.63
+0.03 (+5.55%)
At close · Jul 24
Market Cap
$56.42M
Shares
91.88M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-26 | 2026-06-24 | |
| 8-K | 2026-06-15 | — | |
| 8-K | 2026-05-18 | 2026-05-14 | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| 8-K | 2026-05-01 | 2026-04-30 | |
| DEF 14A | 2026-04-28 | — | |
| 8-K | 2026-04-02 | — | |
| 10-K | 2026-03-23 | 2025-12-31 | |
| 8-K | 2026-03-23 | — | |
| 8-K | 2026-03-13 | 2026-03-11 | |
| 8-K | 2026-02-27 | 2026-02-24 | |
| 8-K | 2026-01-08 | — | |
| 8-K | 2025-11-05 | — | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-10-24 | — | |
| 8-K | 2025-10-20 | 2025-10-17 | |
| 8-K | 2025-09-02 | 2025-08-28 | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-06-12 | — | |
| 8-K | 2025-06-02 | — | |
| 10-Q | 2025-05-07 | 2025-03-31 | |
| DEF 14A | 2025-04-15 | 2025-06-12 | |
| 8-K | 2025-04-09 | — | |
| 10-K | 2025-03-20 | 2024-12-31 | |
| 8-K | 2025-02-28 | 2025-02-27 | |
| 8-K | 2025-01-14 | — | |
| 8-K | 2025-01-13 | 2025-01-10 | |
| 8-K | 2024-12-23 | — | |
| 8-K | 2024-12-02 | — | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-09-23 | — | |
| 8-K | 2024-09-17 | — | |
| 8-K | 2024-09-04 | — | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| DEF 14A | 2024-07-24 | 2024-09-17 | |
| 8-K | 2024-07-10 | 2024-07-09 | |
| 8-K | 2024-06-14 | 2024-06-13 | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| 8-K | 2024-05-02 | 2024-05-01 | |
| DEF 14A | 2024-04-26 | 2024-06-13 | |
| 8-K | 2024-04-01 | — | |
| 10-K | 2024-03-21 | 2023-12-31 | |
| 8-K | 2024-03-21 | 2024-03-19 | |
| 8-K | 2024-03-06 | 2024-02-29 | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-10-31 | — | |
| 10-Q | 2023-08-09 | 2023-06-30 | |
| 8-K | 2023-08-07 | — | |
| 8-K | 2023-06-20 | 2023-06-15 |
Showing 1–50 of 77 filings